Literature DB >> 12627009

S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury.

Philip C Spinella1, Troy Dominguez, Henry R Drott, Jimmy Huh, Lisa McCormick, Anil Rajendra, Jesse Argon, Tracy McIntosh, Mark Helfaer.   

Abstract

OBJECTIVE: To describe normal serum levels of S-100beta in healthy children and determine whether serum S-100beta levels after traumatic brain injury are associated with outcome.
DESIGN: Prospective cohort study.
SETTING: Urban, tertiary care, children's teaching hospital. PATIENTS: A total of 136 healthy children and 27 children with traumatic brain injury.
METHODS: Serum S-100beta levels were measured in 136 healthy children. A total of 27 children with traumatic brain injury had S-100beta levels collected within 12 hrs of injury. Other indices of severity of injury measured were admission Glasgow Coma Scale score, and Pediatric Risk of Mortality score at 24 hrs (PRISM 24). Outcome was measured by the Pediatric Cerebral Performance Category (PCPC) score at hospital discharge and 6 months postinjury or at death.
MEASUREMENTS AND MAIN RESULTS: S-100beta levels in healthy children had a mean of 0.3 microg/L (90% confidence interval, 0.03-1.47) and inversely correlated with age, (r = -.32, p <.001). In children with traumatic brain injury, 6-month postinjury outcome inversely correlated with Glasgow Coma Scale score (r = -.47, p =.01) and correlated with PRISM 24 score (r =.83, p <.001) and S-100beta levels (r =.75, p <.001). Six months postinjury, comparing good outcome (PCPC < or = 3, n = 20) vs. poor outcome (PCPC > or = 4, n = 7), median admission Glasgow Coma Scale scores were 8 (range, 3-15) and 3 (range, 3-7, p =.01), median PRISM 24 scores were 7 (range, 0-19) and 30 (range, 18-35, p <.001), and median S-100beta levels were 0.85 microg/L (range, 0.08-4.8 microg/L) and 3.6 microg/L (range, 1.4-20 microg/L, p <.001), respectively. A serum S-100beta level of > or =2.0 microg/L is associated with poor outcome, with a sensitivity of 86% and a specificity of 95%. The area under the receiver operating curve for S-100beta was 0.94 (+/-0.05).
CONCLUSIONS: Serum S-100beta levels in healthy children have a moderate inverse correlation with age. After traumatic brain injury in children, the acute assessment of serum S-100beta levels seems to be associated with outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627009     DOI: 10.1097/01.CCM.0000053644.16336.52

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  22 in total

1.  Comparison of S100B and NSE between cardiac surgery and interventional therapy for children.

Authors:  Yu Liu; Ying Xu; Da-zhen Li; Yuan Shi; Mao Ye
Journal:  Pediatr Cardiol       Date:  2009-05-27       Impact factor: 1.655

Review 2.  New concepts in treatment of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Anesthesiol Clin       Date:  2009-06

Review 3.  White matter damage after traumatic brain injury: A role for damage associated molecular patterns.

Authors:  Molly Braun; Kumar Vaibhav; Nancy M Saad; Sumbul Fatima; John R Vender; Babak Baban; Md Nasrul Hoda; Krishnan M Dhandapani
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-19       Impact factor: 5.187

Review 4.  Chapter 6 state of the science of pediatric traumatic brain injury: biomarkers and gene association studies.

Authors:  Karin Reuter-Rice; Julia K Eads; Suzanna Boyce Berndt; Ellen Bennett
Journal:  Annu Rev Nurs Res       Date:  2015

Review 5.  [Biomarkers in pediatric polytrauma].

Authors:  H Andruszkow; R Pfeifer; K Horst; P Kobbe; H-C Pape; F Hildebrand
Journal:  Unfallchirurg       Date:  2014-08       Impact factor: 1.000

6.  Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury.

Authors:  Rachel Pardes Berger; Michael C Bazaco; Amy K Wagner; Patrick M Kochanek; Anthony Fabio
Journal:  Dev Neurosci       Date:  2010-09-18       Impact factor: 2.984

Review 7.  Clinical applications of biomarkers in pediatric traumatic brain injury.

Authors:  Simon J I Sandler; Anthony A Figaji; P David Adelson
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

8.  Inability of S100B to predict postconcussion syndrome in children who present to the emergency department with mild traumatic brain injury: a brief report.

Authors:  Lynn Babcock; Terri Byczkowski; Shari L Wade; Mona Ho; Jeffrey J Bazarian
Journal:  Pediatr Emerg Care       Date:  2013-04       Impact factor: 1.454

9.  Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B.

Authors:  Klaus Strobel; Jeannine Skalsky; Victor Kalff; Katrin Baumann; Burkhardt Seifert; Helen Joller-Jemelka; Reinhard Dummer; Hans C Steinert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-28       Impact factor: 9.236

10.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.